Suresnes, France

Zhihua Sui


Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovator Zhihua Sui: Pioneering Cancer Treatment Solutions

Introduction

Zhihua Sui, based in Suresnes, France, is a notable inventor recognized for his significant contributions to cancer treatment through innovative pharmaceutical compounds. With a focus on addressing critical medical needs, Sui has a patent that showcases his inventive prowess in the field of biochemistry.

Latest Patents

Zhihua Sui holds a patent for "Aza-heterobicyclic inhibitors of MAT2A and methods of use for treating cancer." This patent outlines compounds that act as inhibitors of methionine adenosyltransferase isoform 2A (MAT2A). The disclosure presents various compounds according to Formula I, including their pharmaceutically acceptable salts, tautomers, and isotopologues. Notably, these compounds have potential applications in treating cancers associated with the deletion of the gene encoding methylthioadenosine phosphorylase (MTAP).

Career Highlights

Sui is currently associated with Les Laboratoires Servier, where he contributes to groundbreaking pharmaceutical research and development. His work is pivotal in the creation of targeted therapies for cancers, aiming to improve patient outcomes. His patent reflects a blend of scientific innovation and practical application, targeting therapeutic areas with substantial clinical relevance.

Collaborations

Zhihua Sui collaborates with prominent colleagues such as Zenon D. Konteatis and Mingzong Li. Together, they are working towards advancing the understanding of MET2A inhibition and its implications in oncology. These collaborations amplify the impact of Sui’s research, fostering an environment of innovation within the pharmaceutical industry.

Conclusion

Zhihua Sui's innovative work in the development of cancer treatment methodologies through his patented compounds underscores his commitment to enhancing therapeutic options for patients. His research at Les Laboratoires Servier, alongside talented collaborators, positions him as a significant figure in the quest for effective cancer therapies. The advancements resulting from his inventions could pave the way for future breakthroughs in cancer treatment.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…